Form 4: Ginkgo Bioworks Director Receives Stock Units

Ginkgo Bioworks Holdings, Inc. Director Harry Sloan was granted 25,000 restricted stock units under the company's non-employee director compensation program.

Summary

• Harry Sloan, a Director at Ginkgo Bioworks Holdings, Inc., was granted 25,000 restricted stock units (RSUs) on June 11, 2026.
• These RSUs represent a contingent right to receive one share of the Issuer's Class A Common Stock.
• The RSUs are scheduled to vest on the earlier of June 11, 2027, or the day before the next Annual Meeting, provided Sloan continues to serve as a Non-Employee Director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard director compensation event rather than a significant financial or strategic development.

Positives

• Director compensation aligns with continued service, incentivizing long-term commitment.
• Grant of equity to a director indicates confidence in the company's future prospects.

Risks

• Vesting is contingent on continued service, meaning the director could forfeit the RSUs if they step down before the vesting date.
• The value of the RSUs is tied to the performance of Ginkgo Bioworks' Class A Common Stock, which is subject to market volatility.

Future Outlook

The RSUs are set to vest on June 11, 2027, or the day prior to the next Annual Meeting, contingent on continued service as a Non-Employee Director.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to directors is a common practice in the biotechnology and synthetic biology sectors, aligning executive and director incentives with shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs is a form of compensation and dilutes ownership slightly, but it also aligns director interests with long-term shareholder value.
• Employees: This filing does not directly impact employees but reflects standard corporate governance practices.
• Directors: Harry Sloan benefits from the grant, contingent on continued service.

Next Steps

• Director Harry Sloan to continue service as a Non-Employee Director through the vesting date.
• RSUs will vest on the earlier of June 11, 2027, or the day immediately prior to the next Annual Meeting.

Key Dates

Keywords

Ginkgo Bioworks, DNA, Form 4, Director Compensation, Restricted Stock Units, Equity Grant, SEC Filing, Beneficial Ownership